These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2746137)
21. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice. Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological analysis of guinea-pig macrophage chemiluminescence responses to platelet activating factor and opsonized zymosan. Parnham MJ; Bittner C Int J Immunopharmacol; 1986; 8(8):951-9. PubMed ID: 3804536 [TBL] [Abstract][Full Text] [Related]
23. Recombinant human lactoferrin modulates human PBMC derived macrophage responses to BCG and LPS. Hwang SA; Kruzel ML; Actor JK Tuberculosis (Edinb); 2016 Dec; 101S():S53-S62. PubMed ID: 27727130 [TBL] [Abstract][Full Text] [Related]
24. [Effect of C. parvum-activated macrophages on tumor cells: a microcinematographic study]. Guo SY Zhonghua Yi Xue Za Zhi; 1985 Mar; 65(3):140-3. PubMed ID: 3928111 [No Abstract] [Full Text] [Related]
25. Synthesis of nitrite and nitrate in murine macrophage cell lines. Stuehr DJ; Marletta MA Cancer Res; 1987 Nov; 47(21):5590-4. PubMed ID: 3117354 [TBL] [Abstract][Full Text] [Related]
26. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. Stuehr DJ; Marletta MA J Immunol; 1987 Jul; 139(2):518-25. PubMed ID: 3110273 [TBL] [Abstract][Full Text] [Related]
27. Experimental nonspecific immunostimulation by the Propionibacterium acnes vaccine. Koukalová D; Kod'ousek R; Hájek V; Kolár M Acta Univ Palacki Olomuc Fac Med; 1992; 133():19-23. PubMed ID: 1344592 [TBL] [Abstract][Full Text] [Related]
28. Effect of vaccination and the immunomodulators "bacillus of Calmette-Guérin, avridine and Propionibacterium acnes" on rabies in mice. Megid J; Peraçolli MT; Curi PR; Zanetti CR; Cabrera WH; Vassao R; Ito FH Comp Immunol Microbiol Infect Dis; 1998 Oct; 21(4):305-18. PubMed ID: 9775360 [TBL] [Abstract][Full Text] [Related]
29. Triggering effects of BCG vaccine on antitumor and interleukin-1 secretory activity of T cell lymphokine-primed macrophages. Seledtsova GV; Seledtsov VI; Kozlov VA Biomed Pharmacother; 1995; 49(7-8):369-74. PubMed ID: 8562865 [TBL] [Abstract][Full Text] [Related]
30. Role of mononuclear phagocytes in decreased hepatic drug metabolism following administration of Corynebacterium parvum. Soyka LF; Stephens CC; MacPherson BR; Foster RS Int J Immunopharmacol; 1979; 1(2):101-12. PubMed ID: 551956 [No Abstract] [Full Text] [Related]
31. Modifications in the handling in vitro of 125I-labelled keyhole limpet haemocyanin by peritoneal macrophages from mice pretreated with the adjuvant Corynebacterium parvum. Wiener E; Bandieri A Immunology; 1975 Aug; 29(2):265-74. PubMed ID: 1158386 [TBL] [Abstract][Full Text] [Related]
33. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin. Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926 [TBL] [Abstract][Full Text] [Related]
34. Interferon production by Corynebacterium parvum and BCG-activated murine spleen macrophages. Neumann C; Macher E; Sorg C Immunobiology; 1980 Apr; 157(1):12-23. PubMed ID: 6162779 [TBL] [Abstract][Full Text] [Related]
35. Delta-9-tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators. Cabral GA; Mishkin EM J Toxicol Environ Health; 1989; 26(2):175-82. PubMed ID: 2537903 [TBL] [Abstract][Full Text] [Related]
37. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells. Morikawa K; Takeda R; Yamazaki M; Mizuno D Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669 [TBL] [Abstract][Full Text] [Related]
38. Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man. Wan HH; Thatcher N; Mullen PW; Smith GN; Wilkinson PM Br J Cancer; 1979 Apr; 39(4):441-4. PubMed ID: 444399 [TBL] [Abstract][Full Text] [Related]
39. The adjuvant effect of Corynebacterium parvum: T-cell dependence of macrophage activation. Sljivić VS; Watson SR J Exp Med; 1977 Jan; 145(1):45-57. PubMed ID: 299769 [TBL] [Abstract][Full Text] [Related]
40. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum. Tomecki J; Sukiennik J; Kordowiak A Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]